biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by BigDolphinon Feb 23, 2017 4:27pm

148 Views

Post# 25885352

RE:RE:RE:RE:RE:Best Guesses for 2016

Awwwwwww. Don't be such a DYCK jd. Is that what the d stands for. ? You are so pathetic. Quit giving yourself 5 stars. Unreal. Small man syndrome. Maybe Bti has a serum for you. But I highly doubt anything would get through your thick skull. The Forum is all yours little guy.

Bullboard Posts

Changing Europe’s dependency on HREE from China